Estimates of live birth prevalence of children with Down syndrome in the period 1991–2015 in the Netherlands von Graaf, G., Engelen, J. J. M., Gijsbers, A. C. J., Hochstenbach, R., Hoffer, M. J. V., Kooper, A. J. A., Sikkema‐Raddatz, B., Srebniak, M. I., Kevie‐Kersemaekers, A. M. F., Zutven, L. J. C. M., Voorhoeve, E.

Volltext

A live-born child with a mosaic chromosomal pattern of either monosomy 21 or trisomy 4 in different embryonal germ layers von van der Kevie-Kersemaekers, A. M. F., Suijkerbuijk, R. F., Moll, F. C. P., Dijkhuizen, T., van Spaendonck-Zwarts, K. Y., Drok, G., Bouman, K., Sikkema-Raddatz, B.

Volltext

Estimates of live birth prevalence of children with D own syndrome in the period 1991–2015 in the N etherlands von de Graaf, G., Engelen, J. J. M., Gijsbers, A. C. J., Hochstenbach, R., Hoffer, M. J. V., Kooper, A. J. A., Sikkema‐Raddatz, B., Srebniak, M. I., van der Kevie‐Kersemaekers, A. M. F., van Zutven, L. J. C. M., Voorhoeve, E.

Volltext

Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analys... von Kater, Arnon P, Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens H M, van der Kevie-Kersemaekers, Anne-Marie F, Dobber, Johan A, Poulsen, Christian B, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Brieghel, Christian, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T T, Nasserinejad, Kazem, Niemann, Carsten U

Volltext

Does non‐invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population‐based register study von Groot‐van der Mooren, Maurike, Graaf, Gert, Weijerman, Michel E, Hoffer, Mariette J. V, Knijnenburg, Jeroen, Kevie‐Kersemaekers, Anne‐Marie M. F, Kooper, Angelique J. A, Voorhoeve, Els, Sikkema‐Raddatz, Birgit, Zutven, Laura J. C. M, Srebniak, Malgorzata Ilona, Huijsdens‐van Amsterdam, Karin, Engelen, John J. M, Smeets, Dominique, Kaam, Anton H, Cornel, Martina C

Volltext

The idiopathic preterm delivery methylation profile in umbilical cord blood DNA von Fernando, Febilla, Keijser, Remco, Henneman, Peter, van der Kevie-Kersemaekers, Anne-Marie F, Mannens, Marcel Mam, van der Post, Joris Am, Afink, Gijs B, Ris-Stalpers, Carrie

Volltext

PRRT2-related phenotypes in patients with a 16p11.2 deletion von Vlaskamp, Danique R.M., Callenbach, Petra M.C., Rump, Patrick, Giannini, Lucia A.A., Brilstra, Eva H., Dijkhuizen, Trijnie, Vos, Yvonne J., van der Kevie-Kersemaekers, Anne-Marie F., Knijnenburg, Jeroen, de Leeuw, Nicole, van Minkelen, Rick, Ruivenkamp, Claudia A.L., Stegmann, Alexander P.A., Brouwer, Oebele F., van Ravenswaaij-Arts, Conny M.A.

Volltext

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a m... von Kersting, Sabina, Dubois, Julie, Nasserinejad, Kazem, Dobber, Johan A, Mellink, Clemens, van der Kevie-Kersemaekers, Anne-Marie F, Evers, Ludo M, de Boer, Fransien, Koene, Harry R, Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A, van der Spek, Ellen, van der Straaten, Hanneke M, Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F M, Visser, Hein P J, Houtenbos, Ilse, Idink, Cecile A M, Issa, Djamila E, Dompeling, Ellen C, van Zaanen, Henk C T, Veelken, Hendrik, Levenga, Henriette, Tick, Lidwine W, Terpstra, Wim E, Tonino, Sanne H, Boyer, Michelle, Mobasher, Mehrdad, Levin, Mark-David, Kater, Arnon P

Volltext

UNFAVORABLE GENETICS IMPACT MRD RESPONSE TO VENETOCLAX+RITUXIMAB RETREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): PHASE 3 MURANO SUBSTUDY von Wu, J. Q., Seymour, J. F., Eichhorst, B., Hillmen, P., Kipps, T., Langerak, A. W., Owen, C., Dubois, J., Mellink, C., van der Kevie‐Kersemaekers, A., Chyla, B., Jiang, Y., Boyer, M., Thadani‐Mulero, M., Lefebure, M., Kater, A. P.

Volltext

IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY von Wu, J., Bolen, C., Seymour, J.F., Hillmen, P., Eichhorst, B., Eldering, E., Kipps, T.J., Langerak, A.W., Mellink, C., Kevie‐Kersemaekers, A.F., Owen, C., Chyla, B., Punnoose, E.A., Wang, J., Boyer, M., Humphrey, K., Jiang, Y., Kater, A.P.

Volltext

The importance of chromosome studies in Roberts syndrome/SC phocomelia and other cohesinopathies von Gerkes, Erica H, van der Kevie-Kersemaekers, Anne-Marie F, Yakin, Mariam, Smeets, Dominique F.C.M, van Ravenswaaij-Arts, Conny M.A

Volltext

A live-born child with a mosaic chromosomal pattern of either monosomy 21 or trisomy 4 in different embryonal germ layers von van der Kevie-Kersemaekers, A M F, Suijkerbuijk, R F, Moll, F C P, Dijkhuizen, T, van Spaendonck-Zwarts, K Y, Drok, G, Bouman, K, Sikkema-Raddatz, B

Volltext

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL von van der Straten, Lina, Stege, Claudia A. M., Kersting, Sabina, Nasserinejad, Kazem, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie F., Evers, Ludo M., de Boer, Fransien, Koene, Harry R., Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A., van der Spek, Ellen, van der Straaten, Hanneke M., Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F. M., Visser, Hein P. J., Houtenbos, Ilse, Idink, Cecile A. M., Issa, Djamila E., Dompeling, Ellen C., van Zaanen, Henk C. T., Veelken, J. Hendrik, Levenga, Henriette, Tick, Lidwine W., Terpstra, Wim E., Tonino, Sanne H., Westerweel, Peter E., Langerak, Anton W., Kater, Arnon P., Levin, Mark-David, Beckers, M. M. J., Bekker, A., Bellido, M., de Boer, F., Broers, R., Chamuleau, M., Croockewit, A. J., Dompeling, E. C., Eefting, M., van Gelder, M., Hoogendoorn, M., Houtenbos, I., Doorduijn, J. K., Droogendijk, J., van der Griend, R., de Heer, K., Henkens, C. M. A., Idink, C. A. M., Issa, D. E., van Kampen, R., Kater, A. P., Kersting, S., van der Klift, M., Laterveer, L., Levenga, H., Levin, M-D., Mous, R., Nijland, M., Nijziel, M., van Norden, Y., Posthuma, E. F. M., te Raa, G. D., Raymakers, R. A. P., Regelink, J. C., Sandberg, Y., Schaafsma, M. R., Silbermann, M. H., van der Spek, A. C., van der Straaten, H. M., Tanis, B., Terpstra, W. E., Tick, L. W., Tonino, S. H., Veelken, J. H., Velders, G. A., Vlasveld, L., Visser, H. P. J., Vos, J. M. I., Wittebol, S., van Zaanen, H. C. T.

Volltext

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110 von Hengeveld, Paul J., Ertem, Y. Emre, Dubois, Julie M. N., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie, Evers, Ludo M., Heezen, Kim, Kolijn, P. Martijn, Mook, Olaf R. F., Motazacker, M. Mahdi, Nasserinejad, Kazem, Kersting, S., Westerweel, Peter E., Niemann, Carsten U., Kater, Arnon P., Langerak, Anton W., Levin, Mark-David

Volltext

Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands?: A population-based register study von de Groot-van der Mooren, Maurike, de Graaf, Gert, Weijerman, Michel E, Hoffer, Mariette J V, Knijnenburg, Jeroen, van der Kevie-Kersemaekers, Anne-Marie M F, Kooper, Angelique J A, Voorhoeve, Els, Sikkema-Raddatz, Birgit, van Zutven, Laura J C M, Srebniak, Malgorzata Ilona, Huijsdens-van Amsterdam, Karin, Engelen, John J M, Smeets, Dominique, van Kaam, Anton H, Cornel, Martina C

Volltext

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110 von Hengeveld, Paul J, Ertem, Y Emre, Dubois, Julie M N, Mellink, Clemens H M, van der Kevie-Kersemaekers, Anne-Marie, Evers, Ludo M, Heezen, Kim, Kolijn, P Martijn, Mook, Olaf R F, Motazacker, M Mahdi, Nasserinejad, Kazem, Kersting, S, Westerweel, Peter E, Niemann, Carsten U, Kater, Arnon P, Langerak, Anton W, Levin, Mark-David

Volltext

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL von Straten, L. van der, Stege, C.A.M., Kersting, S., Nasserinejad, K., Dubois, J., Dobber, J.A., Mellink, C.H.M., Kevie-Kersemaekers, A.M.F. van der, Evers, L.M., Boer, F. de, Koene, H.R., Schreurs, J., Klift, M. van der, Velders, G.A., Spek, E. van der, Straaten, H.M. van der, Hoogendoorn, M., Gelder, M. van, Posthuma, E.F.M., Visser, H.P.J., Houtenbos, I., Idink, C.A.M., Issa, D.E., Dompeling, E.C., Zaanen, H.C.T. van, Veelken, J.H., Levenga, H., Tick, L.W., Terpstra, W.E., Tonino, S.H., Westerweel, P.E., Langerak, A.W., Kater, A.P., Levin, M.D.

Volltext bestellen

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a m... von Kersting, S., Dubois, J., Nasserinejad, K., Dobber, J.A., Mellink, C., Kevie-Kersemaekers, A.M.F. van der, Evers, L.M., Boer, F. de, Koene, H.R., Schreurs, J., Klift, M. van der, Velders, G.A., Spek, E. van der, Straaten, H.M. van der, Hoogendoorn, M., Gelder, M. van, Posthuma, E.F.M., Visser, H.P.J., Houtenbos, I., Idink, C.A.M., Issa, D.E., Dompeling, E.C., Zaanen, H.C.T. van, Veelken, H., Levenga, H., Tick, L.W., Terpstra, W.E., Tonino, S.H., Boyer, M., Mobasher, M., Levin, M.D., Kater, A.P.

Volltext bestellen